Anna Marei Eichhoff
Impact in
- Physiology top 10%
- Adenosine and Purinergic Signaling
- Infectious Diseases top 10%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Clostridium difficile and Clostridium perfringens research 2
- Co-authors
- Friedrich Koch‐Nolte (7 shared papers)Friedrich Haag (5 shared papers)Klaus Aktories (2 shared papers)Carsten Schwan (2 shared papers)Erica L. Buonomo (1 shared paper)Mahmoud Saleh (1 shared paper)Dena Lyras (1 shared paper)Stacey L. Burgess (1 shared paper)
- Journals
- Current Opinion in Pharmacology (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)Frontiers in Oncology (1 paper)Contrast Media & Molecular Imaging (1 paper)Journal of the American Society of Nephrology (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Anna Marei Eichhoff
7 papers receiving 414 citations
Peers
Comparison fields: 5 of 65
- Physiology 48
- Infectious Diseases 147
- Nephrology 43
- Radiology, Nuclear Medicine and Imaging 89
- Immunology 84
Countries citing papers authored by Anna Marei Eichhoff
This map shows the geographic impact of Anna Marei Eichhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Marei Eichhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Marei Eichhoff more than expected).
Fields of papers citing papers by Anna Marei Eichhoff
This network shows the impact of papers produced by Anna Marei Eichhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Marei Eichhoff. The network helps show where Anna Marei Eichhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Marei Eichhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 142 | |
| 2 | 2019 | 70 | |
| 3 | 2015 | 58 | |
| 4 | 2018 | 50 | |
| 5 | 2015 | 45 | |
| 6 | 2019 | 37 | |
| 7 | 2020 | 13 |
About Anna Marei Eichhoff
Anna Marei Eichhoff is a scholar working on Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Molecular Biology, Physiology and Genetics, having authored 7 papers that have together received 415 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Adenosine and Purinergic Signaling (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Virus-based gene therapy research (2 papers), Adolescent and Pediatric Healthcare (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Physiology (48 citations), Infectious Diseases (147 citations), Nephrology (43 citations), Radiology, Nuclear Medicine and Imaging (89 citations) and Immunology (84 citations). Anna Marei Eichhoff has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Friedrich Koch‐Nolte, Friedrich Haag, Klaus Aktories, Carsten Schwan, Erica L. Buonomo, Mahmoud Saleh, Dena Lyras, Stacey L. Burgess, Nigel P. Minton and William A. Petri. Their work appears in journals such as Current Opinion in Pharmacology, Molecular Therapy — Methods & Clinical Development, Frontiers in Oncology, Contrast Media & Molecular Imaging and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.